Compare TBPH & SNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBPH | SNCY |
|---|---|---|
| Founded | 2013 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 867.0M |
| IPO Year | 2013 | 2021 |
| Metric | TBPH | SNCY |
|---|---|---|
| Price | $16.34 | $16.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | $18.40 | ★ $19.50 |
| AVG Volume (30 Days) | 282.6K | ★ 622.2K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | $15,386,000.00 | ★ $1,126,769,000.00 |
| Revenue This Year | $8.46 | $12.27 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | ★ N/A | $37.60 |
| Revenue Growth | N/A | ★ 4.74 |
| 52 Week Low | $9.10 | $10.14 |
| 52 Week High | $21.03 | $22.29 |
| Indicator | TBPH | SNCY |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 45.66 |
| Support Level | $16.14 | $15.36 |
| Resistance Level | $17.21 | $17.93 |
| Average True Range (ATR) | 0.38 | 0.65 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 29.31 | 49.16 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.